Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program
A Randomized Controlled Trial Study of the Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jing Zhu, Ph.D.
- Phone Number: 2124258833
- Email: jzhu@metisassoc.com
Study Locations
-
-
Georgia
-
East Point, Georgia, United States, 30344
- Recruiting
- Future Foundation
-
Contact:
- Qaadirah Abdur-Rahim
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Schools: attending Woodland and McNair middle schools and projected to attend Banneker high school
- Grade level: Grades 6-8
- Race/ethnicity or tribe: 100% African American
- Gender: 34% male and 66% female (based on current make-up of Future Foundation youth)
- Risk characteristics: 93% of youth will come from low-income families (based on free lunch eligibility)
- Other characteristics: The majority of target youth will also exhibit academic need. 81% will be below proficiency in English language arts and 90% will score not proficient in math. All recruited subjects will be new to Future Foundation services.
Exclusion Criteria:
- Students who have already received Future Foundation services
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: Future Foundation 2.0 PREIS Program
The Future Foundation 2.0 PREIS intervention model will include: a mandatory school-year program that offers after-school programming 4 days a week, including 120 hours of education (direct instruction & homework support), 30 hours of health (social emotional learning & sexual health), and 15 hours of student advocacy; an optional, 4-week summer program that offers 120 hours of programming each summer, including 16 hours of health (social emotional learning - service learning), 104 hours of project-based learning and enrichment (project-based learning in STEM - 64 hours) and enrichment (i.e., field trips, career speakers, and arts and crafts opportunities- 40 hours); and an optional parent engagement program, which will offer monthly parent workshops and quarterly events.
|
The Future Foundation 2.0 PREIS intervention model uses a placed-based collective impact framework to provide a comprehensive intervention model, including: academic support and college and career readiness services, evidence-based social emotional learning instruction to strengthen protective factors and promote healthy transitions to adulthood, and trauma-informed, medically accurate, and age appropriate sexual health education.
Moreover, the 2.0 PREIS program model features a unique student advocacy component designed to ensure that youth and their families receive the wraparound supports necessary for their students to remain on track for school success.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post measure of ever having vaginal sex in the past 3 months
Time Frame: 12 months after baseline
|
A dichotomous measure collected at the end of the program based on self-report questionnaire.
|
12 months after baseline
|
|
Post measure of risk of exposure to sexually transmitted infections in the past 3 months
Time Frame: 12 months after baseline
|
A dichotomous measure collected at the end of the program based on self-report questionnaire.
|
12 months after baseline
|
|
Post measure of ever having unprotected vaginal sex in the past 3 months
Time Frame: 12 months after baseline
|
A dichotomous measure collected at the end of the program based on self-report questionnaire.
|
12 months after baseline
|
|
Follow-up measure of ever having vaginal sex in the past 3 months
Time Frame: 18 months after baseline
|
A dichotomous measure collected six months after the end of program implementation based on self-report questionnaire.
|
18 months after baseline
|
|
Follow up measure of risk of exposure to sexually transmitted infections in the past 3 months
Time Frame: 18 months after baseline
|
A dichotomous measure collected six months after the end of program implementation based on self-report questionnaire.
|
18 months after baseline
|
|
Follow up measure of ever having unprotected vaginal sex in the past 3 months
Time Frame: 18 months after baseline
|
A dichotomous measure collected six months after the end of program implementation based on self-report questionnaire.
|
18 months after baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MetisIRBFFPREIS05062017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.